Jason Bond Picks Service | 3 Stocks Under A Buck I’m Watching Right Now

The story everyone in the small-cap world is talking about is IWM (the Russell 2000 ETF) and how its stalled into resistance. Sure, $160 is an all-important level right now… but there are plenty of other trades going on… and  I’m still hunting down to find my two bread-and-butter setups — the same ones I’ve used to crush … Read more

Jeff Bishop’s Total Alpha Trading Strategy | The Jump on the Week

I can’t recall another time where I’ve witnessed a stock market rally to all-time highs—with such unease, disgust, and hatred. And you know what else? There is an incredible disconnect with the market’s performance and what the raw data is saying… And let’s not forget about all the uncertainty:domestic political tensions as the 2020 election … Read more

Taylor Conway’s Shadow Trader Alert Review – Dark Pools Scanner Revealed

Taylor Conway is best known for his Tactical Edge alerts service. But he has recently released a brand new strategy – Shadow Trader Alerts Service. Taylor Conway Shadow Trader Alerts service is a brand new service that teaches you how to take advantage of the “Dark Pools” that Wall Street Insiders use to make massive … Read more

Jeff Bishop’s Total Alpha Trading Strategy | Three Winning Volatility Trades

There are three ways I think you can play the next volatility spike in the market. If played correctly, it could generate substantial returns for myself—and life changing for others. 3 Winning Volatility Trades First, the VIX isn’t a stock. You can’t trade it on the open exchange. There are three main ways to trade the VIX: ETF … Read more

Kyle Dennis FDA Insider Alerts Strategy | Two Biotech Stocks to Keep an Eye On

The market is stalling at all-time highs… and traders are still trying to piece together the puzzle… However, I’m not one of those traders. Why? I’m focused on trading biotech stocks — they offer explosive opportunities and move at their own rhythm— regardless if the market is grinding higher or set to crash. You see, biotech … Read more